메뉴 건너뛰기




Volumn 170, Issue 3, 2014, Pages 286-290

Ischemic heart disease in systemic inflammatory diseases. An appraisal

Author keywords

Atherosclerosis; Coronary artery disease; Immune system; Systemic inflammatory disease

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYCHLOROQUINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TUMOR NECROSIS FACTOR ALPHA;

EID: 84890972284     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.11.048     Document Type: Review
Times cited : (26)

References (81)
  • 1
    • 0033552883 scopus 로고    scopus 로고
    • Atherosclerosis - An inflammatory disease
    • R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
    • (1999) N Engl J Med , vol.340 , pp. 115-126
    • Ross, R.1
  • 2
    • 34249721444 scopus 로고    scopus 로고
    • The laboratory approach to the diagnosis of autoimmune diseases: Is it time to change?
    • D. Villalta, R. Tozzoli, E. Tonutti, and N. Bizzaro The laboratory approach to the diagnosis of autoimmune diseases: is it time to change? Autoimmun Rev 6 2007 359 365
    • (2007) Autoimmun Rev , vol.6 , pp. 359-365
    • Villalta, D.1    Tozzoli, R.2    Tonutti, E.3    Bizzaro, N.4
  • 3
    • 79958003836 scopus 로고    scopus 로고
    • Chronic inflammatory diseases and cardiovascular risk: A systematic review
    • I. Roifman, P.L. Beck, T.J. Anderson, M.J. Eisenberg, and J. Genest Chronic inflammatory diseases and cardiovascular risk: a systematic review Can J Cardiol 27 2011 174 182
    • (2011) Can J Cardiol , vol.27 , pp. 174-182
    • Roifman, I.1    Beck, P.L.2    Anderson, T.J.3    Eisenberg, M.J.4    Genest, J.5
  • 4
    • 36849063936 scopus 로고    scopus 로고
    • Atherosclerosis and systemic lupus erythematosus: Mechanistic basis of the association
    • M. McMahon, and B.H. Hahn Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association Curr Opin Immunol 19 2007 633 639
    • (2007) Curr Opin Immunol , vol.19 , pp. 633-639
    • McMahon, M.1    Hahn, B.H.2
  • 5
    • 31144476123 scopus 로고    scopus 로고
    • Premature atherosclerotic disease in systemic lupus erythematosus - Role of inflammatory mechanisms
    • E.Y. Rhew, and R. Ramsey-Goldman Premature atherosclerotic disease in systemic lupus erythematosus - role of inflammatory mechanisms Autoimmun Rev 5 2006 101 105
    • (2006) Autoimmun Rev , vol.5 , pp. 101-105
    • Rhew, E.Y.1    Ramsey-Goldman, R.2
  • 6
    • 32644437182 scopus 로고    scopus 로고
    • Mechanisms of disease: Atherosclerosis in autoimmune diseases
    • Y. Sherer, and Y. Shoenfeld Mechanisms of disease: atherosclerosis in autoimmune diseases Nat Clin Pract Rheumatol 2 2006 99 106
    • (2006) Nat Clin Pract Rheumatol , vol.2 , pp. 99-106
    • Sherer, Y.1    Shoenfeld, Y.2
  • 9
    • 13444266513 scopus 로고    scopus 로고
    • Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population-based cohort study
    • H. Maradit-Kremers, C.S. Crowson, and P.J. Nicola et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study Arthritis Rheum 52 2005 402 411
    • (2005) Arthritis Rheum , vol.52 , pp. 402-411
    • Maradit-Kremers, H.1    Crowson, C.S.2    Nicola, P.J.3
  • 10
    • 32144454173 scopus 로고    scopus 로고
    • Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: A case control study
    • K.J. Warrington, P.D. Kent, and R.L. Frye et al. Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study Arthritis Res Ther 7 2005 R984 R991
    • (2005) Arthritis Res Ther , vol.7
    • Warrington, K.J.1    Kent, P.D.2    Frye, R.L.3
  • 11
    • 33751012122 scopus 로고    scopus 로고
    • Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    • C. Han, D.W. Robinson Jr., M.V. Hackett, L.C. Paramore, K.H. Fraeman, and M.V. Bala Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis J Rheumatol 33 2006 2167 2172
    • (2006) J Rheumatol , vol.33 , pp. 2167-2172
    • Han, C.1    Robinson, Jr.D.W.2    Hackett, M.V.3    Paramore, L.C.4    Fraeman, K.H.5    Bala, M.V.6
  • 13
    • 77952940995 scopus 로고    scopus 로고
    • Dyslipidaemia in rheumatoid arthritis: The role of inflammation, drugs, lifestyle and genetic factors
    • T.E. Toms, D.P. Symmons, and G.D. Kitas Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors Curr Vasc Pharmacol 8 2010 301 326
    • (2010) Curr Vasc Pharmacol , vol.8 , pp. 301-326
    • Toms, T.E.1    Symmons, D.P.2    Kitas, G.D.3
  • 14
    • 78149492440 scopus 로고    scopus 로고
    • Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the apolipoprotein-related mortality risk (amoris) study
    • A.G. Semb, T.K. Kvien, and A.H. Aastveit et al. Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the apolipoprotein-related mortality risk (amoris) study Ann Rheum Dis 69 2010 1996 2001
    • (2010) Ann Rheum Dis , vol.69 , pp. 1996-2001
    • Semb, A.G.1    Kvien, T.K.2    Aastveit, A.H.3
  • 15
    • 34247624485 scopus 로고    scopus 로고
    • The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: Roles of inflammation and dyslipidemia
    • B.H. Hahn, J. Grossman, W. Chen, and M. McMahon The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia J Autoimmun 28 2007 69 75
    • (2007) J Autoimmun , vol.28 , pp. 69-75
    • Hahn, B.H.1    Grossman, J.2    Chen, W.3    McMahon, M.4
  • 16
    • 84855172814 scopus 로고    scopus 로고
    • The pathogenesis of rheumatoid arthritis
    • I.B. McInnes, and G. Schett The pathogenesis of rheumatoid arthritis N Engl J Med 365 2011 2205 2219
    • (2011) N Engl J Med , vol.365 , pp. 2205-2219
    • McInnes, I.B.1    Schett, G.2
  • 17
    • 78650679617 scopus 로고    scopus 로고
    • Cardiovascular disease in rheumatoid arthritis: State of the art and future perspectives
    • G.D. Kitas, and S.E. Gabriel Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives Ann Rheum Dis 70 2011 8 14
    • (2011) Ann Rheum Dis , vol.70 , pp. 8-14
    • Kitas, G.D.1    Gabriel, S.E.2
  • 18
    • 23744474780 scopus 로고    scopus 로고
    • Paradoxical effect of body mass index on survival in rheumatoid arthritis: Role of comorbidity and systemic inflammation
    • A. Escalante, R.W. Haas, and I. del Rincon Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation Arch Intern Med 165 2005 1624 1629
    • (2005) Arch Intern Med , vol.165 , pp. 1624-1629
    • Escalante, A.1    Haas, R.W.2    Del Rincon, I.3
  • 19
    • 8444233962 scopus 로고    scopus 로고
    • Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis
    • H.M. Kremers, P.J. Nicola, C.S. Crowson, K.V. Ballman, and S.E. Gabriel Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis Arthritis Rheum 50 2004 3450 3457
    • (2004) Arthritis Rheum , vol.50 , pp. 3450-3457
    • Kremers, H.M.1    Nicola, P.J.2    Crowson, C.S.3    Ballman, K.V.4    Gabriel, S.E.5
  • 20
    • 0029877828 scopus 로고    scopus 로고
    • Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins
    • A.J. Silman, J. Newman, and A.J. MacGregor Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins Arthritis Rheum 39 1996 732 735
    • (1996) Arthritis Rheum , vol.39 , pp. 732-735
    • Silman, A.J.1    Newman, J.2    Macgregor, A.J.3
  • 21
    • 84855178011 scopus 로고    scopus 로고
    • Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis
    • U. Bergstrom, L.T. Jacobsson, J.A. Nilsson, G. Berglund, and C. Turesson Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis Rheumatology (Oxford) 50 2011 2005 2013
    • (2011) Rheumatology (Oxford) , vol.50 , pp. 2005-2013
    • Bergstrom, U.1    Jacobsson, L.T.2    Nilsson, J.A.3    Berglund, G.4    Turesson, C.5
  • 23
    • 82655182044 scopus 로고    scopus 로고
    • Current smoking status is associated to a non-ACR 50 response in early rheumatoid arthritis. A cohort study
    • J. Rojas-Serrano, L.L. Perez, and C.G. Garcia et al. Current smoking status is associated to a non-ACR 50 response in early rheumatoid arthritis. A cohort study Clin Rheumatol 30 2011 1589 1593
    • (2011) Clin Rheumatol , vol.30 , pp. 1589-1593
    • Rojas-Serrano, J.1    Perez, L.L.2    Garcia, C.G.3
  • 24
    • 79953162113 scopus 로고    scopus 로고
    • Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis
    • L. Klareskog, V. Malmstrom, K. Lundberg, L. Padyukov, and L. Alfredsson Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis Semin Immunol 23 2011 92 98
    • (2011) Semin Immunol , vol.23 , pp. 92-98
    • Klareskog, L.1    Malmstrom, V.2    Lundberg, K.3    Padyukov, L.4    Alfredsson, L.5
  • 25
    • 75749118959 scopus 로고    scopus 로고
    • Eular evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
    • M.J. Peters, D.P. Symmons, and D. McCarey et al. Eular evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis Ann Rheum Dis 69 2010 325 331
    • (2010) Ann Rheum Dis , vol.69 , pp. 325-331
    • Peters, M.J.1    Symmons, D.P.2    McCarey, D.3
  • 26
    • 0037432305 scopus 로고    scopus 로고
    • Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis
    • D.H. Solomon, E.W. Karlson, and E.B. Rimm et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis Circulation 107 2003 1303 1307
    • (2003) Circulation , vol.107 , pp. 1303-1307
    • Solomon, D.H.1    Karlson, E.W.2    Rimm, E.B.3
  • 27
    • 0031861699 scopus 로고    scopus 로고
    • Plasma viscosity and the risk of coronary heart disease: Results from the Monica-Augsburg cohort study, 1984 to 1992
    • W. Koenig, M. Sund, B. Filipiak, A. Doring, H. Lowel, and E. Ernst Plasma viscosity and the risk of coronary heart disease: results from the Monica-Augsburg cohort study, 1984 to 1992 Arterioscler Thromb Vasc Biol 18 1998 768 772
    • (1998) Arterioscler Thromb Vasc Biol , vol.18 , pp. 768-772
    • Koenig, W.1    Sund, M.2    Filipiak, B.3    Doring, A.4    Lowel, H.5    Ernst, E.6
  • 28
    • 82955194825 scopus 로고    scopus 로고
    • Hemorheological parameters are related to subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis patients
    • M.J. Santos, L.M. Pedro, and H. Canhao et al. Hemorheological parameters are related to subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis patients Atherosclerosis 219 2011 821 826
    • (2011) Atherosclerosis , vol.219 , pp. 821-826
    • Santos, M.J.1    Pedro, L.M.2    Canhao, H.3
  • 29
    • 0345072560 scopus 로고    scopus 로고
    • Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset
    • S. Wallberg-Jonsson, H. Johansson, M.L. Ohman, and S. Rantapaa-Dahlqvist Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset J Rheumatol 26 1999 2562 2571
    • (1999) J Rheumatol , vol.26 , pp. 2562-2571
    • Wallberg-Jonsson, S.1    Johansson, H.2    Ohman, M.L.3    Rantapaa-Dahlqvist, S.4
  • 30
    • 33644876592 scopus 로고    scopus 로고
    • Relationship between brachial artery flow-mediated dilation and coronary flow reserve in patients with peripheral artery disease
    • T. Pellegrino, G. Storto, and P.P. Filardi et al. Relationship between brachial artery flow-mediated dilation and coronary flow reserve in patients with peripheral artery disease J Nucl Med 46 2005 1997 2002
    • (2005) J Nucl Med , vol.46 , pp. 1997-2002
    • Pellegrino, T.1    Storto, G.2    Filardi, P.P.3
  • 31
    • 27144508749 scopus 로고    scopus 로고
    • Relation of brachial artery flow-mediated vasodilation to significant coronary artery disease in patients with peripheral arterial disease
    • P. Perrone-Filardi, A. Cuocolo, and G. Brevetti et al. Relation of brachial artery flow-mediated vasodilation to significant coronary artery disease in patients with peripheral arterial disease Am J Cardiol 96 2005 1337 1341
    • (2005) Am J Cardiol , vol.96 , pp. 1337-1341
    • Perrone-Filardi, P.1    Cuocolo, A.2    Brevetti, G.3
  • 32
    • 0036623628 scopus 로고    scopus 로고
    • Carotid intima-media thickness at different sites: Relation to incident myocardial infarction; The Rotterdam Study
    • A. Iglesias del Sol, M.L. Bots, D.E. Grobbee, A. Hofman, and J.C. Witteman Carotid intima-media thickness at different sites: relation to incident myocardial infarction; the Rotterdam Study Eur Heart J 23 2002 934 940
    • (2002) Eur Heart J , vol.23 , pp. 934-940
    • Iglesias Del Sol, A.1    Bots, M.L.2    Grobbee, D.E.3    Hofman, A.4    Witteman, J.C.5
  • 33
    • 0033531215 scopus 로고    scopus 로고
    • Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group
    • D.H. O'Leary, J.F. Polak, R.A. Kronmal, T.A. Manolio, G.L. Burke, and S.K. Wolfson Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group N Engl J Med 340 1999 14 22
    • (1999) N Engl J Med , vol.340 , pp. 14-22
    • O'Leary, D.H.1    Polak, J.F.2    Kronmal, R.A.3    Manolio, T.A.4    Burke, G.L.5    Wolfson, Jr.S.K.6
  • 34
    • 0037116573 scopus 로고    scopus 로고
    • Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force
    • M.C. Corretti, T.J. Anderson, and E.J. Benjamin et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2002 257 265
    • (2002) J Am Coll Cardiol , vol.39 , pp. 257-265
    • Corretti, M.C.1    Anderson, T.J.2    Benjamin, E.J.3
  • 35
    • 0036273301 scopus 로고    scopus 로고
    • Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis
    • Y. Kumeda, M. Inaba, and H. Goto et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis Arthritis Rheum 46 2002 1489 1497
    • (2002) Arthritis Rheum , vol.46 , pp. 1489-1497
    • Kumeda, Y.1    Inaba, M.2    Goto, H.3
  • 36
    • 43949086231 scopus 로고    scopus 로고
    • Impaired coronary microvascular function and increased intima-media thickness in rheumatoid arthritis
    • O. Ciftci, S. Yilmaz, and S. Topcu et al. Impaired coronary microvascular function and increased intima-media thickness in rheumatoid arthritis Atherosclerosis 198 2008 332 337
    • (2008) Atherosclerosis , vol.198 , pp. 332-337
    • Ciftci, O.1    Yilmaz, S.2    Topcu, S.3
  • 37
    • 80052044660 scopus 로고    scopus 로고
    • Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: A position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology
    • [1993a, 1993b]
    • P. Perrone-Filardi, S. Achenbach, and S. Mohlenkamp et al. Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology Eur Heart J 32 2011 1986 1993 [1993a, 1993b]
    • (2011) Eur Heart J , vol.32 , pp. 1986-1993
    • Perrone-Filardi, P.1    Achenbach, S.2    Mohlenkamp, S.3
  • 38
    • 20144375468 scopus 로고    scopus 로고
    • Pathogenesis of lupus nephritis: An update
    • S. Tang, S.L. Lui, and K.N. Lai Pathogenesis of lupus nephritis: an update Nephrology (Carlton) 10 2005 174 179
    • (2005) Nephrology (Carlton) , vol.10 , pp. 174-179
    • Tang, S.1    Lui, S.L.2    Lai, K.N.3
  • 39
    • 0037668545 scopus 로고    scopus 로고
    • Pathogenesis of systemic lupus erythematosus
    • C.C. Mok, and C.S. Lau Pathogenesis of systemic lupus erythematosus J Clin Pathol 56 2003 481 490
    • (2003) J Clin Pathol , vol.56 , pp. 481-490
    • Mok, C.C.1    Lau, C.S.2
  • 41
    • 0347922145 scopus 로고    scopus 로고
    • Premature coronary-artery atherosclerosis in systemic lupus erythematosus
    • Y. Asanuma, A. Oeser, and A.K. Shintani et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus N Engl J Med 349 2003 2407 2415
    • (2003) N Engl J Med , vol.349 , pp. 2407-2415
    • Asanuma, Y.1    Oeser, A.2    Shintani, A.K.3
  • 42
    • 0026459695 scopus 로고
    • Risk factors for coronary artery disease in patients with systemic lupus erythematosus
    • M. Petri, S. Perez-Gutthann, D. Spence, and M.C. Hochberg Risk factors for coronary artery disease in patients with systemic lupus erythematosus Am J Med 93 1992 513 519
    • (1992) Am J Med , vol.93 , pp. 513-519
    • Petri, M.1    Perez-Gutthann, S.2    Spence, D.3    Hochberg, M.C.4
  • 43
    • 83955165924 scopus 로고    scopus 로고
    • Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients
    • L. Yang, J. Tao, and X. Tang et al. Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients J Eur Acad Dermatol Venereol 26 2012 95 101
    • (2012) J Eur Acad Dermatol Venereol , vol.26 , pp. 95-101
    • Yang, L.1    Tao, J.2    Tang, X.3
  • 44
    • 3342912111 scopus 로고    scopus 로고
    • Systemic lupus erythematosus: An independent risk factor for endothelial dysfunction in women
    • M. El-Magadmi, H. Bodill, and Y. Ahmad et al. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women Circulation 110 2004 399 404
    • (2004) Circulation , vol.110 , pp. 399-404
    • El-Magadmi, M.1    Bodill, H.2    Ahmad, Y.3
  • 45
    • 77952469211 scopus 로고    scopus 로고
    • Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - A prospective cohort study
    • J. Gustafsson, I. Gunnarsson, and O. Borjesson et al. Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study Arthritis Res Ther 11 2009 R186
    • (2009) Arthritis Res Ther , vol.11 , pp. 186
    • Gustafsson, J.1    Gunnarsson, I.2    Borjesson, O.3
  • 46
    • 24744462995 scopus 로고    scopus 로고
    • High sensitivity C-reactive protein in systemic lupus erythematosus: Relation to disease activity, clinical presentation and implications for cardiovascular risk
    • E.V. Barnes, S. Narain, and A. Naranjo et al. High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk Lupus 14 2005 576 582
    • (2005) Lupus , vol.14 , pp. 576-582
    • Barnes, E.V.1    Narain, S.2    Naranjo, A.3
  • 47
    • 2942733373 scopus 로고    scopus 로고
    • Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: A rationale for therapeutic intervention
    • M. Aringer, and J.S. Smolen Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention Lupus 13 2004 344 347
    • (2004) Lupus , vol.13 , pp. 344-347
    • Aringer, M.1    Smolen, J.S.2
  • 48
    • 0347381206 scopus 로고    scopus 로고
    • Systemic lupus erythematosus and accelerated atherosclerosis
    • B.H. Hahn Systemic lupus erythematosus and accelerated atherosclerosis N Engl J Med 349 2003 2379 2380
    • (2003) N Engl J Med , vol.349 , pp. 2379-2380
    • Hahn, B.H.1
  • 49
    • 4444249222 scopus 로고    scopus 로고
    • Platelet-activating factor-acetylhydrolase and other novel risk and protective factors for cardiovascular disease in systemic lupus erythematosus
    • A. Cederholm, E. Svenungsson, and D. Stengel et al. Platelet-activating factor-acetylhydrolase and other novel risk and protective factors for cardiovascular disease in systemic lupus erythematosus Arthritis Rheum 50 2004 2869 2876
    • (2004) Arthritis Rheum , vol.50 , pp. 2869-2876
    • Cederholm, A.1    Svenungsson, E.2    Stengel, D.3
  • 50
    • 0035899949 scopus 로고    scopus 로고
    • Risk factors for cardiovascular disease in systemic lupus erythematosus
    • E. Svenungsson, K. Jensen-Urstad, and M. Heimburger et al. Risk factors for cardiovascular disease in systemic lupus erythematosus Circulation 104 2001 1887 1893
    • (2001) Circulation , vol.104 , pp. 1887-1893
    • Svenungsson, E.1    Jensen-Urstad, K.2    Heimburger, M.3
  • 51
    • 65849131630 scopus 로고    scopus 로고
    • Macrovascular disease in systemic sclerosis: The tip of an iceberg?
    • J.J. Belch, S. McSwiggan, and C. Lau Macrovascular disease in systemic sclerosis: the tip of an iceberg? Rheumatology (Oxford) 47 Suppl. 5 2008 v16 v17
    • (2008) Rheumatology (Oxford) , vol.47 , Issue.SUPPL. 5
    • Belch, J.J.1    McSwiggan, S.2    Lau, C.3
  • 52
    • 0016244871 scopus 로고
    • Pericardial disease in scleroderma (systemic sclerosis)
    • McWhorter JEt, and E.C. LeRoy Pericardial disease in scleroderma (systemic sclerosis) Am J Med 57 1974 566 575
    • (1974) Am J Med , vol.57 , pp. 566-575
    • Jet, M.1    Leroy, E.C.2
  • 53
    • 0021350660 scopus 로고
    • Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma
    • W.P. Follansbee, E.I. Curtiss, and T.A. Medsger Jr. et al. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma N Engl J Med 310 1984 142 148
    • (1984) N Engl J Med , vol.310 , pp. 142-148
    • Follansbee, W.P.1    Curtiss, E.I.2    Medsger, Jr.T.A.3
  • 54
    • 0014483819 scopus 로고
    • Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls
    • W.A. D'Angelo, J.F. Fries, A.T. Masi, and L.E. Shulman Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls Am J Med 46 1969 428 440
    • (1969) Am J Med , vol.46 , pp. 428-440
    • D'Angelo, W.A.1    Fries, J.F.2    Masi, A.T.3    Shulman, L.E.4
  • 55
    • 42449111699 scopus 로고    scopus 로고
    • A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: Coronary artery calcification in cases and controls
    • V. Khurma, C. Meyer, and G.S. Park et al. A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls Arthritis Rheum 59 2008 591 597
    • (2008) Arthritis Rheum , vol.59 , pp. 591-597
    • Khurma, V.1    Meyer, C.2    Park, G.S.3
  • 56
    • 0344511824 scopus 로고    scopus 로고
    • Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis
    • M.M. Cerinic, G. Valentini, and G.G. Sorano et al. Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis Semin Arthritis Rheum 32 2003 285 295
    • (2003) Semin Arthritis Rheum , vol.32 , pp. 285-295
    • Cerinic, M.M.1    Valentini, G.2    Sorano, G.G.3
  • 57
    • 0033498335 scopus 로고    scopus 로고
    • Autoimmunity and vascular involvement in systemic sclerosis (ssc)
    • M.B. Kahaleh, and E.C. LeRoy Autoimmunity and vascular involvement in systemic sclerosis (ssc) Autoimmunity 31 1999 195 214
    • (1999) Autoimmunity , vol.31 , pp. 195-214
    • Kahaleh, M.B.1    Leroy, E.C.2
  • 58
    • 34347214839 scopus 로고    scopus 로고
    • Endothelial dysfunction precedes atherosclerosis in systemic sclerosis - Relevance for prevention of vascular complications
    • G. Szucs, O. Timar, and Z. Szekanecz et al. Endothelial dysfunction precedes atherosclerosis in systemic sclerosis - relevance for prevention of vascular complications Rheumatology (Oxford) 46 2007 759 762
    • (2007) Rheumatology (Oxford) , vol.46 , pp. 759-762
    • Szucs, G.1    Timar, O.2    Szekanecz, Z.3
  • 59
    • 80053626840 scopus 로고    scopus 로고
    • ESC guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)
    • V. Regitz-Zagrosek, C. Blomstrom Lundqvist, and C. Borghi et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology (ESC) Eur Heart J 32 2011 3147 3197
    • (2011) Eur Heart J , vol.32 , pp. 3147-3197
    • Regitz-Zagrosek, V.1    Blomstrom Lundqvist, C.2    Borghi, C.3
  • 60
    • 21544463151 scopus 로고    scopus 로고
    • Lipoprotein profile in limited systemic sclerosis
    • E.F. Borba, C.T. Borges, and E. Bonfa Lipoprotein profile in limited systemic sclerosis Rheumatol Int 25 2005 379 383
    • (2005) Rheumatol Int , vol.25 , pp. 379-383
    • Borba, E.F.1    Borges, C.T.2    Bonfa, E.3
  • 61
    • 34548837999 scopus 로고    scopus 로고
    • Myocardial and vascular dysfunction in systemic sclerosis: The potential role of noninvasive assessment in asymptomatic patients
    • A. D'Andrea, P. Caso, and S. Cuomo et al. Myocardial and vascular dysfunction in systemic sclerosis: the potential role of noninvasive assessment in asymptomatic patients Int J Cardiol 121 2007 298 301
    • (2007) Int J Cardiol , vol.121 , pp. 298-301
    • D'Andrea, A.1    Caso, P.2    Cuomo, S.3
  • 62
    • 33847398727 scopus 로고    scopus 로고
    • Circulating levels of nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis
    • O. Kaloudi, G. Basta, and F. Perfetto et al. Circulating levels of nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis Rheumatology (Oxford) 46 2007 412 416
    • (2007) Rheumatology (Oxford) , vol.46 , pp. 412-416
    • Kaloudi, O.1    Basta, G.2    Perfetto, F.3
  • 63
    • 0031793425 scopus 로고    scopus 로고
    • Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud's phenomenon
    • J. Lekakis, M. Mavrikakis, and C. Papamichael et al. Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud's phenomenon Am Heart J 136 1998 905 912
    • (1998) Am Heart J , vol.136 , pp. 905-912
    • Lekakis, J.1    Mavrikakis, M.2    Papamichael, C.3
  • 64
    • 33751064759 scopus 로고    scopus 로고
    • Risk of serious NSAID-related gastrointestinal events during long-term exposure: A systematic review
    • D. Schaffer, T. Florin, and C. Eagle et al. Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic review Med J Aust 185 2006 501 506
    • (2006) Med J Aust , vol.185 , pp. 501-506
    • Schaffer, D.1    Florin, T.2    Eagle, C.3
  • 65
    • 34848863617 scopus 로고    scopus 로고
    • Non-steroidal anti-inflammatory drugs and myocardial infarctions: Comparative systematic review of evidence from observational studies and randomised controlled trials
    • P.A. Scott, G.H. Kingsley, C.M. Smith, E.H. Choy, and D.L. Scott Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials Ann Rheum Dis 66 2007 1296 1304
    • (2007) Ann Rheum Dis , vol.66 , pp. 1296-1304
    • Scott, P.A.1    Kingsley, G.H.2    Smith, C.M.3    Choy, E.H.4    Scott, D.L.5
  • 66
    • 84903891016 scopus 로고    scopus 로고
    • Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: A nationwide cohort study
    • J. Lindhardsen, G.H. Gislason, and S. Jacobsen et al. Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study Ann Rheum Dis 2013
    • (2013) Ann Rheum Dis
    • Lindhardsen, J.1    Gislason, G.H.2    Jacobsen, S.3
  • 67
    • 67650073256 scopus 로고    scopus 로고
    • Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: A meta-analysis
    • V. Ravindran, S. Rachapalli, and E.H. Choy Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis Rheumatology (Oxford) 48 2009 807 811
    • (2009) Rheumatology (Oxford) , vol.48 , pp. 807-811
    • Ravindran, V.1    Rachapalli, S.2    Choy, E.H.3
  • 68
    • 27744566645 scopus 로고    scopus 로고
    • A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal
    • E.H. Choy, C. Smith, C.J. Dore, and D.L. Scott A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal Rheumatology (Oxford) 44 2005 1414 1421
    • (2005) Rheumatology (Oxford) , vol.44 , pp. 1414-1421
    • Choy, E.H.1    Smith, C.2    Dore, C.J.3    Scott, D.L.4
  • 70
    • 84867498972 scopus 로고    scopus 로고
    • Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: A longitudinal evaluation of the lipid-lowering effect
    • E. Cairoli, M. Rebella, N. Danese, V. Garra, and E.F. Borba Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect Lupus 21 2012 1178 1182
    • (2012) Lupus , vol.21 , pp. 1178-1182
    • Cairoli, E.1    Rebella, M.2    Danese, N.3    Garra, V.4    Borba, E.F.5
  • 71
    • 77950441072 scopus 로고    scopus 로고
    • The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: A systematic literature review
    • S.L. Westlake, A.N. Colebatch, and J. Baird et al. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review Rheumatology (Oxford) 49 2010 295 307
    • (2010) Rheumatology (Oxford) , vol.49 , pp. 295-307
    • Westlake, S.L.1    Colebatch, A.N.2    Baird, J.3
  • 72
    • 21044458269 scopus 로고    scopus 로고
    • Mycophenolate Mofetil Cardiac Study I. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients
    • H.J. Eisen, J. Kobashigawa, and A. Keogh et al. Mycophenolate Mofetil Cardiac Study I. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients J Heart Lung Transplant 24 2005 517 525
    • (2005) J Heart Lung Transplant , vol.24 , pp. 517-525
    • Eisen, H.J.1    Kobashigawa, J.2    Keogh, A.3
  • 73
    • 84866410515 scopus 로고    scopus 로고
    • Mycophenolate mofetil (MMF) does not slow the progression of subclinical atherosclerosis in SLE over 2 years
    • A.N. Kiani, L.S. Magder, and M. Petri Mycophenolate mofetil (MMF) does not slow the progression of subclinical atherosclerosis in SLE over 2 years Rheumatol Int 32 2012 2701 2705
    • (2012) Rheumatol Int , vol.32 , pp. 2701-2705
    • Kiani, A.N.1    Magder, L.S.2    Petri, M.3
  • 74
    • 61649089518 scopus 로고    scopus 로고
    • Sustained improvement of vascular endothelial function during anti-tnfalpha treatment in rheumatoid arthritis patients
    • P.I. Sidiropoulos, P. Siakka, and K. Pagonidis et al. Sustained improvement of vascular endothelial function during anti-tnfalpha treatment in rheumatoid arthritis patients Scand J Rheumatol 38 2009 6 10
    • (2009) Scand J Rheumatol , vol.38 , pp. 6-10
    • Sidiropoulos, P.I.1    Siakka, P.2    Pagonidis, K.3
  • 75
    • 17644393196 scopus 로고    scopus 로고
    • Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis
    • D.N. Kiortsis, A.K. Mavridis, S. Vasakos, S.N. Nikas, and A.A. Drosos Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis Ann Rheum Dis 64 2005 765 766
    • (2005) Ann Rheum Dis , vol.64 , pp. 765-766
    • Kiortsis, D.N.1    Mavridis, A.K.2    Vasakos, S.3    Nikas, S.N.4    Drosos, A.A.5
  • 76
    • 27744544317 scopus 로고    scopus 로고
    • Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor- A blockade in patients with rheumatoid arthritis
    • I. Macías, S. García-Pérez, M. Ruiz-Tudela, F. Medina, N. Chozas, and J.A. Girón-González Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor- A blockade in patients with rheumatoid arthritis J Rheumatol 32 2005 2102 2108
    • (2005) J Rheumatol , vol.32 , pp. 2102-2108
    • Macías, I.1    García-Pérez, S.2    Ruiz-Tudela, M.3    Medina, F.4    Chozas, N.5    Girón-González, J.A.6
  • 77
    • 2642571902 scopus 로고    scopus 로고
    • Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody
    • C. Gonzalez-Juanatey, A. Testa, A. Garcia-Castelo, C. Garcia-Porrua, J. Llorca, and M.A. Gonzalez-Gay Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody Arthritis Rheum 51 2004 447 450
    • (2004) Arthritis Rheum , vol.51 , pp. 447-450
    • Gonzalez-Juanatey, C.1    Testa, A.2    Garcia-Castelo, A.3    Garcia-Porrua, C.4    Llorca, J.5    Gonzalez-Gay, M.A.6
  • 78
    • 5444224197 scopus 로고    scopus 로고
    • Effect of anti tnfalpha therapy on arterial diameter and wall shear stress and HDL cholesterol
    • C. Irace, G. Mancuso, E. Fiaschi, A. Madia, G. Sesti, and A. Gnasso Effect of anti tnfalpha therapy on arterial diameter and wall shear stress and HDL cholesterol Atherosclerosis 177 2004 113 118
    • (2004) Atherosclerosis , vol.177 , pp. 113-118
    • Irace, C.1    Mancuso, G.2    Fiaschi, E.3    Madia, A.4    Sesti, G.5    Gnasso, A.6
  • 79
    • 80052074383 scopus 로고    scopus 로고
    • Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: A meta-analysis of randomized controlled trials
    • C. Ryan, C.L. Leonardi, and J.G. Krueger et al. Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials JAMA 306 2011 864 871
    • (2011) JAMA , vol.306 , pp. 864-871
    • Ryan, C.1    Leonardi, C.L.2    Krueger, J.G.3
  • 80
    • 84869497484 scopus 로고    scopus 로고
    • European guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)
    • Fifth Joint Task Force of the European Society of C, European Association of E, and European Association of Percutaneous Cardiovascular I et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Eur J Prev Cardiol 19 2012 585 667
    • (2012) Eur J Prev Cardiol , vol.19 , pp. 585-667
  • 81
    • 79960539641 scopus 로고    scopus 로고
    • ESC/EAS guidelines for the management of dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
    • Z. Reiner, A.L. Catapano, and G. De Backer et al. ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J 32 2011 1769 1818
    • (2011) Eur Heart J , vol.32 , pp. 1769-1818
    • Reiner, Z.1    Catapano, A.L.2    De Backer, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.